Document Detail

Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals.
MedLine Citation:
PMID:  21949623     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Rigid control of blood pressure (BP) is essential to prevent cardiovascular disease. However, only about 40% of hypertensive patients undergoing pharmacological intervention with a single agent achieve their BP goals in contemporary clinical practice. Combined therapy using currently available agents is effective in maximizing treatment outcome, although it raises medical costs and decreases the drug compliance rate. To overcome such negative consequences, a combination tablet containing an angiotensin II receptor blocker (ARB) with a small dose of hydrochlorothiazide (HCTZ) is now available on the international market, including Japan. This article briefly describes the unique properties of telmisartan, a highly selective ARB for the angiotensin II type 1 receptor, including its long-acting characteristics and recent prospective multicenter randomized clinical trials, followed by a description of a newly-introduced combination tablet in Japan, which contains telmisartan and HCTZ. This article also reviews its safety and efficacy based on currently available evidence. Finally, evidence comparing telmisartan/HCTZ with other combination therapies is presented.
Satoshi Morimoto; Nobuyuki Takahashi; Tatsuyori Morita; Kazunori Someya; Nagaoki Toyoda; Toshiji Iwasaka
Related Documents :
15679913 - Influence of passive leg movements on blood circulation on the tilt table in healthy ad...
9509453 - Presyncope during progressive hypovolaemia simulated by lower body negative pressure is...
7021633 - Effect of peep on gas exchange, pulmonary mechanics, and hemodynamics in adult respirat...
Publication Detail:
Type:  Journal Article     Date:  2010-06-03
Journal Detail:
Title:  Integrated blood pressure control     Volume:  3     ISSN:  1178-7104     ISO Abbreviation:  Integr Blood Press Control     Publication Date:  2010  
Date Detail:
Created Date:  2011-09-28     Completed Date:  2011-11-10     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101562709     Medline TA:  Integr Blood Press Control     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  73-9     Citation Subset:  -    
Second Department of Internal Medicine, Kansai Medical University 2-3-1, Shinmachi, Hirakata, Osaka 573-1191, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness.
Next Document:  Impact of telmisartan in modifying vascular risk.